Koree Khongphand-Buckman Discusses Marketing and Business Development Trends for 2022
09 February 2022
Foley & Lardner LLP Chief Marketing and Business Development Officer Koree Khongphand-Buckman is quoted in the Wisconsin Lawyer article, “What’s Hot, What’s Not: National Practice Trends 2022,” about marketing and business development trends in the legal industry for 2022.
“We need to bring the whole of the law firm to the whole of the client,” Khongphand-Buckman said, and “help clients solve not only legal but also business-related issues.” She also discusses the need to continuously strengthen client relationships and see clients in the same way that they see themselves.
People
![Koree Khongpand-Buckman headshot.](https://www.foley.com/wp-content/uploads/2024/03/Khongphand-Buckman_Koree_26293-416x416.jpg)
Koree Khongphand-Buckman
Chief Marketing & Business Development Officer
[email protected]
Denver
720.437.2019
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”